Communications of the ACM
ACM Opinion
Why Big Pharma Wants to Collect 2 Million Genomes
Geneticist David Goldstein will help the company to incorporate genetic sequences into better drug-development programmes.
Credit: AstraZeneca
Five months after announcing its intentions to gather genome sequences from 2 million people, pharmaceutical giant AstraZeneca has selected geneticist David Goldstein to head up the task.
From Nature
View Full Article
No entries found